secwatch.observer — SEC 8-K summary
======================================

Issuer:     Notable Labs, Ltd. (—)
CIK:        0001603207
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001493152-23-006353
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vascular Biogenics transfers listing to Nasdaq Capital Market; gets 180-day extension to meet bid price rule
--------------------------------------------------------------------------------

- Transferred from Nasdaq Global Market to Nasdaq Capital Market effective March 2, 2023; symbol remains VBLT.
- Received 180-day extension until August 28, 2023 to regain compliance with $1.00 minimum bid price.
- Must have closing bid price of at least $1.00 for 10 consecutive business days during extension period.
- Previously received deficiency notice on August 31, 2022 for bid price below $1.00 for 30 consecutive days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1603207/000149315223006353/0001493152-23-006353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1603207/000149315223006353/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-006353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer